Coming Soon: Conexiant’s news site is becoming MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more.
Infectious Disease
Partner With Us
Advertisement
Conexiant chevron_right Infectious Disease chevron_right DOOR framework shows similar outcomes in skin infection trials
From the Journals

DOOR framework shows similar outcomes in skin infection trials

“Using DOOR can provide clinicians and patients with a better understanding of the benefits and risks of new anti-infectives being studied to treat skin infections.” 

MDSpire News
3 Topic Commentaries

DOOR framework shows similar outcomes in skin infection trials

  • Thomas L. Holland, MD, MSc-GH

    Infectious Diseases

    •

    Duke University School of Medicine

    The ABSSSI DOOR demonstrated similar overall clinical outcomes between treatment arms for OASIS-1 and OASIS-2.

    Source
  • Vance G. Fowler Jr., MD, MHS

    Infectious Diseases

    •

    Duke University School of Medicine

    Partial credit and subgroup analyses demonstrated similar overall results.

    Source
  • Sara E. Cosgrove, MD, MS

    Infectious Diseases

    •

    Johns Hopkins University School of Medicine

    In OASIS-2, applying a health-related quality-of-life score as a "tiebreaker" did not significantly change the DOOR probability.

    Source

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.